Ignite Creation Date:
2024-05-06 @ 3:17 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04585997
Status:
UNKNOWN
Last Update Posted:
2020-10-14
First Post:
2020-09-30
Brief Title:
Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - Choosebetweenamab
Sponsor:
University of Newcastle Australia
Organization:
University of Newcastle Australia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-30
First Submit QC Date:
October 6 2020
Study First Post Date:
2020-10-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-06
Last Update Post Date:
2020-10-14
Last Update Post Date Type:
ACTUAL